Lincoln Pharmaceuticals Ltd share price logo

Lincoln Pharma Share Price

NSE: LINCOLN

BSE: 531633

Small Cap

Healthcare Sector

₹458.10

-3.00

(-0.65%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Lincoln Pharma Stock Performance

as on February 6, 2026 at 3:08 pm IST

  • Day's Low

    Day's High

    ₹452.90
    ₹460.55
    downward going graph

    1.14%

    Downside

    0.53%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹440.00
    ₹808.80
    downward going graph

    3.95%

    Downside

    76.56%

    Upside

    downward going graph

Lincoln Pharma share price movements today

Previous Close
₹461.10
Open
₹460.00
Volume
7,996.00
Upper Circuit
₹553.30
Lower Circuit
₹368.90
Day's Low - High
₹452.90 - ₹460.55
52 Week Low - High
₹440.00 - ₹808.80

Lincoln Pharma Historical Returns

1 Month Return
-3.52 %
3 Month Return
-11.85 %
1 Year Return
-39.53 %
3 Year Return
+ 46.06 %
5 Year Return
+ 113.27 %

Lincoln Pharma Fundamentals

as on February 6, 2026 at 3:08 pm IST

Market Cap

₹923.57 Cr

Return on Equity (ROE)

13.02

PE Ratio (TTM)

11.54

Return on capital employed (ROCE)

17.42

Industry PE ratio

40.92

Beta (LTM)

0.95

P/B Ratio

1.64

Dividend Yield

0.33

PEG Ratio

-1.39

Quarterly Earnings Growth YOY

-24.12

EPS (TTM)

41.11

Sector

Pharmaceuticals

Book Value

335.34

Technical Analysis

Bearish

View Technical Analysis

Lincoln Pharma Stock Valuation

as on February 6, 2026 at 3:08 pm IST

Lincoln Pharma in the last 5 years

  • Overview

  • Trends

Lowest (3.58x)

March 23, 2020

Today (11.54x)

February 5, 2026

Industry (40.92x)

February 5, 2026

Highest (19.77x)

December 9, 2024

LowHigh

Today’s Price to Earnings Ratio: 11.54x

Lincoln Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lincoln Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Lincoln Pharmaceuticals Ltd image
Lincoln Pharmaceuticals Ltd
NA923.5722.65%0.5082623
Decipher Labs Ltd image
Decipher Labs Ltd
NA8.45-15.3%0.51-622
Sai Life Sciences Ltd image
Sai Life Sciences Ltd
BUY17,127.681.21%0.581701,694
Panacea Biotec Ltd image
Panacea Biotec Ltd
NA2,278.5316.07%0.53-9559
Biofil Chemicals & Pharmaceuticals Ltd image
Biofil Chemicals & Pharmaceuticals Ltd
NA61.08-11.1%0.00133
See all

Lincoln Pharma Share Price Target

Get share price movements and forecasts by analysts on Lincoln Pharma .

Source: S&P Global Market Intelligence

Lincoln Pharma Stock’s Investor Sentiment and Interest

Search interest for Lincoln Pharmaceuticals Ltd Stock has increased by 23% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:23% versus previous 30 day period

Lincoln Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
112.46
135.62
155.99
146.45
142.49
147.28
161.21
146.55
168.18
154.07
163.36
Other Income
3.9
7.69
8.69
11.02
7.02
10.41
9.98
8.97
-6.88
15.27
7.23
Total Income
116.36
143.31
164.68
157.47
149.51
157.69
171.19
155.52
161.3
169.34
170.6
Expenses
95.82
114.9
124.84
116.79
124.11
124.55
132.83
122.89
141.46
130.26
137.94
Operating Profit
16.64
20.72
31.15
29.66
18.38
22.73
28.38
23.66
26.72
23.81
25.42
Operating Profit Margin %
14.8%
15.28%
19.97%
20.25%
12.9%
15.43%
17.6%
16.14%
15.89%
15.45%
15.56%
Profit Before Interest, Tax and Depreciation
20.54
28.41
39.84
40.68
25.4
33.14
38.36
32.63
19.84
39.08
32.66
Interest
1.15
0.42
0.39
0.15
0.5
0.44
0.35
0.73
0.37
0.21
0.23
Depreciation
2.41
2.55
2.58
2.81
2.69
3.22
3.22
3.22
3.23
3.48
3.62
Profit Before Tax
16.98
25.44
36.87
37.72
22.21
29.48
34.79
28.68
16.24
35.39
28.81
Tax Paid
4.41
6.43
9.21
9.67
3.62
5.8
8.45
7.92
4.67
7.71
8.83
Profit After Tax
12.56
19.01
27.65
28.04
18.6
23.67
26.33
20.77
11.58
27.68
19.98
Total Net profit including share of profit / Loss from associate company
12.56
19.01
27.65
28.04
18.6
23.67
26.33
20.77
11.58
27.68
19.98
EPS
6.27
9.49
13.81
14
9.28
11.82
13.15
10.37
5.78
13.82
9.98
Actual EPS
6.27
9.49
13.81
14
9.28
11.82
13.15
10.37
5.78
13.82
9.98
Adjusted EPS
6.27
9.49
13.81
14
9.28
11.82
13.15
10.37
5.78
13.82
9.98
Diluted EPS
6.27
9.49
13.81
14
9.28
11.82
13.15
10.37
5.78
13.82
9.98

Lincoln Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
360.26
360.61
366.15
386.49
424.19
472.12
510.31
580.55
623.23
Other Income
2.73
5.45
5.63
11.04
5.66
10
22.47
34.42
22.48
Total Income
362.99
366.07
371.78
397.53
429.85
482.12
532.78
614.97
645.71
Expenses
313.48
308.3
298.91
320.95
337.01
376.64
421.11
480.64
521.74
Operating Profit
46.78
52.31
67.24
65.54
87.18
95.48
89.2
99.91
101.49
Operating Profit Margin %
12.99%
14.51%
18.36%
16.96%
20.55%
20.22%
17.48%
17.21%
16.28%
Profit Before Interest, Tax and Depreciation
49.51
57.77
72.87
76.58
92.84
105.48
111.68
134.33
123.97
Interest
6.66
5.41
4
2.02
1.56
1.45
2.03
1.46
1.88
Depreciation
5.51
6.11
6.68
7.33
7.56
8.09
9.17
10.62
12.9
Profit Before Tax
37.34
46.25
62.19
67.23
83.72
95.94
100.48
122.25
109.19
Tax Paid
9.2
11.59
13.45
15.77
21.47
26.58
27.58
28.93
26.85
Profit After Tax
28.13
34.65
48.74
51.47
62.25
69.36
72.9
93.3
82.35
Total Net profit including share of profit / Loss from associate company
28.13
34.65
48.74
51.47
62.25
69.36
72.9
93.3
82.35
EPS
15.73
17.31
24.36
25.72
31.07
34.63
36.4
46.58
41.11
Actual EPS
15.73
17.31
24.36
25.72
31.07
34.63
36.4
46.58
41.11
Adjusted EPS
15.73
17.31
24.36
25.72
31.07
34.63
36.4
46.58
41.11
Diluted EPS
15.73
17.31
24.36
25.72
31.07
34.63
36.4
46.58
41.11

Lincoln Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
44.8
25.04
26.63
52.84
75.42
69.27
76.13
39.26
63.22
93.02
Cash Flow from Investing Activities
-41.7
-25.49
-11.78
-18.18
-30.88
-64.22
-78.08
-36.64
-57.34
-78.95
Cash Flow from Financing Activities
-3.42
0.3
-11.41
-35.76
-37.75
-5.74
-2.56
-4.49
-5.17
-6.41
Net Cash Flow
-0.32
-0.14
3.45
-1.11
6.77
-0.7
-4.5
-1.88
0.7
7.67

Lincoln Pharma Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
47%
48.67%
50.53%
49.8%
49.53%
49.78%
49.78%
49.78%
49.78%
49.78%
49.78%
49.78%
DII
0%
0%
0%
0%
0.05%
0.04%
0%
0%
0.01%
0.01%
0.01%
0.01%
FII
0%
0%
2.59%
0%
3.93%
3.95%
5.19%
5.16%
5%
5.14%
4.72%
4.7%
Public
51.73%
49.58%
46.88%
46.91%
46.49%
46.24%
45.03%
45.06%
45.22%
45.07%
45.49%
45.52%
Total Outstanding Shares
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
2,00,29,728
Total Shareholders
29,088
27,480
28,670
29,316
31,375
29,967
31,330
31,848
31,867
31,784
32,370
31,026

Mutual Funds that own Lincoln Pharma Stock

Check out the Mutual Funds with significant holdings in Lincoln Pharma .

Funds
Holdings
Shares Held
Bandhan BSE Healthcare Index Fund Direct Growth
Bandhan BSE Healthcare Index Fund Direct Growth
0.03%
122

Lincoln Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Lincoln Pharma .

  • Lincoln Pharmaceuticals Ltd Earnings Results

    Lincoln Pharmaceuticals Ltd’s net profit fell -24.12% since last year same period to ₹19.98Cr in the Q2 2025-2026. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated -27.82% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Lincoln Pharmaceuticals Ltd Dividends May,2025

    In the quarter ending March 2025, Lincoln Pharmaceuticals Ltd has declared dividend of ₹1.80 per share on 22 May 2025 - translating a dividend yield of 0.38%.

    Read More about Dividends

Indices Featuring Lincoln Pharma Stock

Check stock indices that include Lincoln Pharma .

BSE Healthcare

₹41,947.56

-0.50 (▲210.87%)

Insights on Lincoln Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 45.49% to 45.52% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 155.52 Cr → 170.6 Cr (in ₹), with an average increase of 3.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 157.6% return, outperforming this stock by 111.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 49.78% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 25.8% return, outperforming this stock by 65.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, LINCOLN stock has moved down by -39.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 27.68 Cr → 19.98 Cr (in ₹), with an average decrease of 27.8% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 4.72% to 4.70% in Dec 2025 quarter

About Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals, established in January 1979 as a partnership firm, was converted into a public limited company in January 1995. Primarily set up to manufacture pharmaceutical formulations such as tablets, capsules, syrups and ointments, they also obtained products from other licensed manufacturers to meet the demands of small volume parenterals. In order to increase production capacity, the company set up a modern formulation plant in Khatraj, Gujarat, and established an in-house laboratory for quality control and R&D. To fund its projects, the firm launched a public issue in February 1996, and in the year 2000, they were granted ISO 9002 and WHO certification. As a result, Lincoln Pharmaceuticals is now a leading manufacturer of quality pharmaceuticals that is continuously working to improve its operations.

Revenue: ₹163.36Cr as on September 2025 (Q2 FY26)
Net Profit: ₹19.98Cr as on September 2025 (Q2 FY26)
Listing date: 17 Dec, 2015
Chairperson Name: Kishorbhai M Shah
OrganisationLincoln Pharmaceuticals Ltd
HeadquartersAhmedabad
IndustryPharmaceuticals
CEOKishorbhai M Shah
E-voting on sharesClick here to vote

FAQs

What is Lincoln Pharma share price today?

Lincoln Pharma share price today stands at ₹458.1 as on . Lincoln Pharma share today touched a day high of ₹460.55 and a low of ₹452.9.

What is the 52 week high and 52 week low range for Lincoln Pharma share?

Lincoln Pharma touched a 52 week high of ₹808.8 and a 52 week low of ₹440. Lincoln Pharma share price today i.e. is trending at ₹458.1, which is -43.36% down from its 52 week high and 4.11% up from its 52 week low.

What is Lincoln Pharma 's market capitalisation today?

Lincoln Pharma market capitalisation is ₹923.57 Cr as on .

How to buy Lincoln Pharma shares?

To buy Lincoln Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for LINCOLN or Lincoln Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Lincoln Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Lincoln Pharma trading volume today?

Lincoln Pharma trading volume is 7,996.00 as on . This means that 7,996.00 shares of Lincoln Pharma were bought and sold on the stock market during today's trading session.